Hatteras’ mission is to create transformative healthcare companies in the research-driven, undercapitalized regions of the Southeast and Mid-Atlantic. Over half of our portfolio companies were created with our initial investment.

At Hatteras Venture Partners, we believe that breakthrough science and entrepreneurial innovation have the power to create valuable new ways of treating and diagnosing disease, providing value for our investors and transforming human health.

The Hatteras team brings operational experience, a renowned strategic partner network, and a successful investment track record. We are passionate about utilizing our backgrounds to engage entrepreneurs and enhance the value of their companies.


Latest News

Hatteras Venture Partners Announces the Final Closing of Hatteras Venture Partners V, LP

January 5, 2017

Firm Exceeds Fund Target of $150 million   DURHAM N.C., January 5, 2017  – Hatteras Venture Partners announced today the final closing of Hatteras Venture Partners V (HVP V) with…

More News